kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex BRAFV600E in colorectal cancer reduces

BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer

SKU: 44716608469 · From eipa.cz